Global and United States Prostate-specific Antigen (PSA) Testing Market Report & Forecast 2023-2028

Report ID: 1872774 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Prostate-specific Antigen (PSA) Testing Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Prostate-specific Antigen (PSA) Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size for the Year 2017-2028
        1.2.2 Global Prostate-specific Antigen (PSA) Testing Market Size for the Year 2017-2028
    1.3 Prostate-specific Antigen (PSA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Prostate-specific Antigen (PSA) Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Prostate-specific Antigen (PSA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Prostate-specific Antigen (PSA) Testing Market Dynamics
        1.4.1 Prostate-specific Antigen (PSA) Testing Industry Trends
        1.4.2 Prostate-specific Antigen (PSA) Testing Market Drivers
        1.4.3 Prostate-specific Antigen (PSA) Testing Market Challenges
        1.4.4 Prostate-specific Antigen (PSA) Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Prostate-specific Antigen (PSA) Testing by Type
    2.1 Prostate-specific Antigen (PSA) Testing Market Segment by Type
        2.1.1 CLIA Method
        2.1.2 ELISA Method
    2.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2028)
    2.4 United States Prostate-specific Antigen (PSA) Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2028)
3 Prostate-specific Antigen (PSA) Testing by Application
    3.1 Prostate-specific Antigen (PSA) Testing Market Segment by Application
        3.1.1 Screening
        3.1.2 Post-treatment Monitoring
        3.1.3 Other
    3.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2028)
    3.4 United States Prostate-specific Antigen (PSA) Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2028)
4 Global Prostate-specific Antigen (PSA) Testing Competitor Landscape by Company
    4.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Company
        4.1.1 Top Global Prostate-specific Antigen (PSA) Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue by Player (2017-2022)
    4.2 Global Prostate-specific Antigen (PSA) Testing Concentration Ratio (CR)
        4.2.1 Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate-specific Antigen (PSA) Testing in 2021
        4.2.3 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Prostate-specific Antigen (PSA) Testing Headquarters, Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Prostate-specific Antigen (PSA) Testing Headquarters and Area Served
        4.3.2 Global Prostate-specific Antigen (PSA) Testing Companies Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Prostate-specific Antigen (PSA) Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Prostate-specific Antigen (PSA) Testing Market Size by Company
        4.5.1 Top Prostate-specific Antigen (PSA) Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Prostate-specific Antigen (PSA) Testing Revenue by Players (2020, 2021 & 2022)
5 Global Prostate-specific Antigen (PSA) Testing Market Size by Region
    5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2028)
        5.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017-2022
        5.2.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Prostate-specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Prostate-specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Company Details
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
        7.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.1.5 Abbott Recent Development
    7.2 Boston Scientific Corporation
        7.2.1 Boston Scientific Corporation Company Details
        7.2.2 Boston Scientific Corporation Business Overview
        7.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
        7.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.2.5 Boston Scientific Corporation Recent Development
    7.3 Bayer AG
        7.3.1 Bayer AG Company Details
        7.3.2 Bayer AG Business Overview
        7.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
        7.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.3.5 Bayer AG Recent Development
    7.4 Siemens Healthcare
        7.4.1 Siemens Healthcare Company Details
        7.4.2 Siemens Healthcare Business Overview
        7.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        7.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.4.5 Siemens Healthcare Recent Development
    7.5 DiaSorin
        7.5.1 DiaSorin Company Details
        7.5.2 DiaSorin Business Overview
        7.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
        7.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.5.5 DiaSorin Recent Development
    7.6 Roche
        7.6.1 Roche Company Details
        7.6.2 Roche Business Overview
        7.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
        7.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.6.5 Roche Recent Development
    7.7 Beckman Coulter
        7.7.1 Beckman Coulter Company Details
        7.7.2 Beckman Coulter Business Overview
        7.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
        7.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.7.5 Beckman Coulter Recent Development
    7.8 PerkinElmer
        7.8.1 PerkinElmer Company Details
        7.8.2 PerkinElmer Business Overview
        7.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
        7.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.8.5 PerkinElmer Recent Development
    7.9 Tosoh
        7.9.1 Tosoh Company Details
        7.9.2 Tosoh Business Overview
        7.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
        7.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.9.5 Tosoh Recent Development
    7.10 Ortho Clinical
        7.10.1 Ortho Clinical Company Details
        7.10.2 Ortho Clinical Business Overview
        7.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
        7.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.10.5 Ortho Clinical Recent Development
    7.11 Fujirebio
        7.11.1 Fujirebio Company Details
        7.11.2 Fujirebio Business Overview
        7.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
        7.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.11.5 Fujirebio Recent Development
    7.12 Mediwatch
        7.12.1 Mediwatch Company Details
        7.12.2 Mediwatch Business Overview
        7.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
        7.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.12.5 Mediwatch Recent Development
    7.13 BodiTech
        7.13.1 BodiTech Company Details
        7.13.2 BodiTech Business Overview
        7.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
        7.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.13.5 BodiTech Recent Development
    7.14 Bristol-Myers Squibb Company
        7.14.1 Bristol-Myers Squibb Company Company Details
        7.14.2 Bristol-Myers Squibb Company Business Overview
        7.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
        7.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.14.5 Bristol-Myers Squibb Company Recent Development
    7.15 GE Healthcare
        7.15.1 GE Healthcare Company Details
        7.15.2 GE Healthcare Business Overview
        7.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        7.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.15.5 GE Healthcare Recent Development
    7.16 Endocare
        7.16.1 Endocare Company Details
        7.16.2 Endocare Business Overview
        7.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
        7.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.16.5 Endocare Recent Development
    7.17 Merck＆Co.
        7.17.1 Merck＆Co. Company Details
        7.17.2 Merck＆Co. Business Overview
        7.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
        7.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.17.5 Merck＆Co. Recent Development
    7.18 Medtronic
        7.18.1 Medtronic Company Details
        7.18.2 Medtronic Business Overview
        7.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
        7.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.18.5 Medtronic Recent Development
    7.19 Sanofi-Aventis SA
        7.19.1 Sanofi-Aventis SA Company Details
        7.19.2 Sanofi-Aventis SA Business Overview
        7.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
        7.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        7.19.5 Sanofi-Aventis SA Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Prostate-specific Antigen (PSA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Prostate-specific Antigen (PSA) Testing Market Trends
    Table 3. Prostate-specific Antigen (PSA) Testing Market Drivers
    Table 4. Prostate-specific Antigen (PSA) Testing Market Challenges
    Table 5. Prostate-specific Antigen (PSA) Testing Market Restraints
    Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prostate-specific Antigen (PSA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prostate-specific Antigen (PSA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prostate-specific Antigen (PSA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prostate-specific Antigen (PSA) Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prostate-specific Antigen (PSA) Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Player, 2017-2022
    Table 13. Global Prostate-specific Antigen (PSA) Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Table 15. Top Players of Prostate-specific Antigen (PSA) Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Prostate-specific Antigen (PSA) Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Prostate-specific Antigen (PSA) Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Prostate-specific Antigen (PSA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Prostate-specific Antigen (PSA) Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Prostate-specific Antigen (PSA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Prostate-specific Antigen (PSA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Prostate-specific Antigen (PSA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Prostate-specific Antigen (PSA) Testing Product
    Table 33. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Boston Scientific Corporation Company Details
    Table 36. Boston Scientific Corporation Business Overview
    Table 37. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
    Table 38. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 39. Boston Scientific Corporation Recent Development
    Table 40. Bayer AG Company Details
    Table 41. Bayer AG Business Overview
    Table 42. Bayer AG Prostate-specific Antigen (PSA) Testing Product
    Table 43. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 44. Bayer AG Recent Development
    Table 45. Siemens Healthcare Company Details
    Table 46. Siemens Healthcare Business Overview
    Table 47. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 48. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 49. Siemens Healthcare Recent Development
    Table 50. DiaSorin Company Details
    Table 51. DiaSorin Business Overview
    Table 52. DiaSorin Prostate-specific Antigen (PSA) Testing Product
    Table 53. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 54. DiaSorin Recent Development
    Table 55. Roche Company Details
    Table 56. Roche Business Overview
    Table 57. Roche Prostate-specific Antigen (PSA) Testing Product
    Table 58. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 59. Roche Recent Development
    Table 60. Beckman Coulter Company Details
    Table 61. Beckman Coulter Business Overview
    Table 62. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
    Table 63. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 64. Beckman Coulter Recent Development
    Table 65. PerkinElmer Company Details
    Table 66. PerkinElmer Business Overview
    Table 67. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
    Table 68. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 69. PerkinElmer Recent Development
    Table 70. Tosoh Company Details
    Table 71. Tosoh Business Overview
    Table 72. Tosoh Prostate-specific Antigen (PSA) Testing Product
    Table 73. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 74. Tosoh Recent Development
    Table 75. Ortho Clinical Company Details
    Table 76. Ortho Clinical Business Overview
    Table 77. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
    Table 78. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 79. Ortho Clinical Recent Development
    Table 80. Fujirebio Company Details
    Table 81. Fujirebio Business Overview
    Table 82. Fujirebio Prostate-specific Antigen (PSA) Testing Product
    Table 83. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 84. Fujirebio Recent Development
    Table 85. Mediwatch Company Details
    Table 86. Mediwatch Business Overview
    Table 87. Mediwatch Prostate-specific Antigen (PSA) Testing Product
    Table 88. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 89. Mediwatch Recent Development
    Table 90. BodiTech Company Details
    Table 91. BodiTech Business Overview
    Table 92. BodiTech Prostate-specific Antigen (PSA) Testing Product
    Table 93. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 94. BodiTech Recent Development
    Table 95. Bristol-Myers Squibb Company Company Details
    Table 96. Bristol-Myers Squibb Company Business Overview
    Table 97. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
    Table 98. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 99. Bristol-Myers Squibb Company Recent Development
    Table 100. GE Healthcare Company Details
    Table 101. GE Healthcare Business Overview
    Table 102. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 103. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 104. GE Healthcare Recent Development
    Table 105. Endocare Company Details
    Table 106. Endocare Business Overview
    Table 107. Endocare Prostate-specific Antigen (PSA) Testing Product
    Table 108. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 109. Endocare Recent Development
    Table 110. Merck＆Co. Company Details
    Table 111. Merck＆Co. Business Overview
    Table 112. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product
    Table 113. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 114. Merck＆Co. Recent Development
    Table 115. Medtronic Company Details
    Table 116. Medtronic Business Overview
    Table 117. Medtronic Prostate-specific Antigen (PSA) Testing Product
    Table 118. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 119. Medtronic Recent Development
    Table 120. Sanofi-Aventis SA Company Details
    Table 121. Sanofi-Aventis SA Business Overview
    Table 122. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
    Table 123. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 124. Sanofi-Aventis SA Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prostate-specific Antigen (PSA) Testing Product Picture
    Figure 2. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prostate-specific Antigen (PSA) Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Prostate-specific Antigen (PSA) Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Prostate-specific Antigen (PSA) Testing Market Share in Global 2017-2028
    Figure 7. Prostate-specific Antigen (PSA) Testing Report Years Considered
    Figure 8. Product Picture of CLIA Method
    Figure 9. Product Picture of ELISA Method
    Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Type in 2022 & 2028
    Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    Figure 13. United States Prostate-specific Antigen (PSA) Testing Market Share by Type in 2022 & 2028
    Figure 14. United States Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    Figure 16. Product Picture of Screening
    Figure 17. Product Picture of Post-treatment Monitoring
    Figure 18. Product Picture of Other
    Figure 19. Global Prostate-specific Antigen (PSA) Testing Market Share by Application in 2022 & 2028
    Figure 20. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    Figure 22. United States Prostate-specific Antigen (PSA) Testing Market Share by Application in 2022 & 2028
    Figure 23. United States Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    Figure 25. North America Prostate-specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Prostate-specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Prostate-specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 54. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 55. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 56. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 57. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 59. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 60. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 61. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 62. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 63. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 64. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 65. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 67. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 68. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 69. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 70. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 71. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Frequently Asked Questions
Prostate-specific Antigen (PSA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate-specific Antigen (PSA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate-specific Antigen (PSA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports